Detalhe da pesquisa
1.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis
; 78(2): 338-348, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633258
2.
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance.
J Infect Dis
; 227(12): 1348-1363, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806690
3.
Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study.
Clin Infect Dis
; 76(11): 1980-1988, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36694363
4.
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
Clin Infect Dis
; 76(3): e1168-e1176, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031405
5.
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.
Clin Infect Dis
; 76(9): 1615-1625, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36611252
6.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(53): 1637-1646, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921274
7.
Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
Clin Infect Dis
; 74(8): 1329-1337, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320171
8.
Role of Age in the Spread of Influenza, 2011-2019: Data From the US Influenza Vaccine Effectiveness Network.
Am J Epidemiol
; 191(3): 465-471, 2022 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34274963
9.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(5152): 1616-1624, 2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580430
10.
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1335-1342, 2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264840
11.
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(4): 139-145, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085224
12.
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(7): 255-263, 2022 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176007
13.
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(9): 352-358, 2022 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239634
14.
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
MMWR Morb Mortal Wkly Rep
; 71(29): 931-939, 2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862287
15.
Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016-2017 and 2017-2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
J Infect Dis
; 223(12): 2062-2071, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140094
16.
Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators.
Clin Infect Dis
; 73(12): 2240-2247, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050659
17.
Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017.
Clin Infect Dis
; 72(7): 1147-1157, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32006430
18.
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018.
Clin Infect Dis
; 73(3): 386-392, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270198
19.
Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
Clin Infect Dis
; 73(11): 1973-1981, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245243
20.
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.
MMWR Morb Mortal Wkly Rep
; 70(18): 674-679, 2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956782